What is the recommended treatment for patients with Psychogenic Non-Epileptic Seizures (PNES)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Psychogenic Non-Epileptic Seizures (PNES)

The primary treatment for PNES is psychiatric referral for psychological therapy, specifically cognitive behavioral therapy (CBT), which achieves seizure freedom in 47% of patients and ≥50% seizure reduction in 82% of patients. 1

Immediate Management: Accurate Diagnosis and Communication

The most critical first step is explaining the diagnosis carefully to the patient using a multidisciplinary approach—this alone is an effective therapeutic intervention. 2

  • Avoid prescribing anticonvulsants, as 80% of PNES patients are inappropriately given antiepileptic drugs despite lacking epilepsy 3
  • Video-EEG recording of an event is the gold standard for confirming diagnosis 2
  • Be aware that 10-20% of PNES patients also have true epilepsy, complicating management decisions 3

Definitive Treatment: Psychiatric Referral

Refer all PNES patients for psychiatric treatment immediately after diagnosis, as 72% of patients achieve resolution of PNES with psychiatric treatment. 3

Specific Psychological Interventions (in order of evidence strength):

  • Cognitive Behavioral Therapy (CBT): First-line psychological treatment with strongest evidence 4, 1
  • Manual-based psychotherapy for seizures: 12-session protocol reduces seizures by 46% per month 5
  • Psychodynamic therapy: Alternative when CBT unavailable 1
  • Mindfulness-based interventions: Adjunctive option 1
  • Psychoeducation alone: Minimum intervention when formal therapy inaccessible 1

Treatment Delivery Options:

  • Video telehealth is equally effective as in-person therapy, eliminating access barriers for rural patients 5
  • Treatment via telehealth achieved 46% monthly seizure reduction and significant improvements in depression, anxiety, and quality of life 5

Avoid Common Pitfalls

Do NOT prescribe anticonvulsants for PNES—they provide no benefit and expose patients to unnecessary medication risks including respiratory depression, cardiac effects, and CNS toxicity. 3

  • Studies show PNES patients undergo extensive invasive testing (lumbar punctures, radiation exposure) and receive inappropriate anticonvulsants in 60-80% of cases 3
  • Anticonvulsant prescription reinforces the incorrect belief that seizures are epileptic, hindering psychological treatment engagement 4

Address Perpetuating Factors

Identify and manage psychological stressors, as mental stress increases PNES frequency and severity. 3

  • Screen for anxiety and depression—present in one-third of PNES patients, particularly adolescents 3
  • Educate patients that PNES is a benign condition with tendency toward natural remission to reduce psychological burden 3
  • Address sleep deprivation and anxiety triggers that precipitate attacks 3

Assess Underlying Psychological Mechanisms

Evaluate for trauma history, dissociative symptoms, and physical symptom reporting patterns, as these are the most consistent correlates of PNES. 6

  • Trait dissociation and traumatic event exposure are common but not universal 6
  • Physical symptom reporting is consistently elevated in PNES patients 6
  • Note the heterogeneity of PNES patients—predisposing, precipitating, and perpetuating factors vary case-by-case 2

Prognosis and Long-term Management

Counsel patients that 25-33% of PNES cases become chronic despite treatment, but the majority improve with appropriate psychological intervention. 4

  • Measure outcomes beyond seizure frequency: quality of life, global functioning, depression, and anxiety scores all improve with treatment 5
  • Quality of life improvements (measured by QOLIE-31) and health status (SF-36) are significant outcome measures 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.